Cytokines: Past, Present, and Future

Menkin V. Chemical basis of fever.Science. 1944;100:337–338.

Bennett IL Jr, Beeson PB. Studies on the pathogenesis of fever. II. Characterization of fever-producing substances from polymorphonuclear leukocytes and from the fluid of sterile exudates.J Exp Med. 1953;98:493–508.

Levi-Montalcini R, Hamburger V. A diffusible agent of mouse sarcoma producing hyperplasia of sympathetic ganglia and hyperneurotization of the chick embryo.J Exp Zool. 1953;123:233–388.

Isaacs A, Lindenmann J. Virus interference. I. Interferons.Proc R Soc Ser B Biol Sci. 1957;147:258–267.

Gowans JL. The recirculation of lymphocytes from blood to lymph in the rat.J Physiol. 1959;146:54–69.

Nowell PC. Phytohemagglutinin: an imitator of mitosis in cultures of normal human leukocytes.Cancer Res. 1960;20:462–467.

Pearmain G, Lycette RR, Fitzgerald PH. Tuberculin induced mitosis in peripheral blood leukocytes.Lancet. 1963;1:637–638.

Bain ML, Vas M, Lowenstein L. The development of large immature mononuclear cells in mixed leukocyte cultures.Blood. 1964;23:108–116.

Kasakura S, Lowenstein L. A factor stimulating DNA synthesis derived from the medium of leukocyte cultures.Nature. 1965;208:794–795.

David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.Proc Natl Acad Sci U S A. 1966;56:73–77.

Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.Science. 1966;153:80–82.

Ruddle NH,Waksman BH. Cytotoxic effect of lymphocyte-antigen interaction in delayed hypersensitivity.Science. 1967;157:1060–1062.

Granger GA, Williams TW. Lymphocyte cytotoxicity in vitro: activation and release of a cytotoxic factor.Nature. 1968;218:1253–1254.

Weiser WY, Temple TA, Witek-Giannotti JS, Remold HG, Clark CC, David JR. Molecular cloning of cDNA encoding a human macrophage migration inhibitory factor.Proc Natl Acad Sci U S A. 1989;86:7522–7526.

Nathan CF, Karnovksy ML, David JR. Alterations of macrophage functions by mediators from lymphocytes.J Exp Med. 1971;133:1356–1376.

Schreiber RD, Celada A. Molecular characterization of interferon γ as a macrophage activating factor. In: Pick E, ed.Lymphokines. London, UK: Acad Press; 1985:87–118.

Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson G. An endotoxin induced serum factor that causes necrosis of tumors.Proc Natl Acad Sci U S A. 1975;72:3666–3670.

Gordon J, MacLean LD. A lymphocyte-stimulating factor produced in vitro.Nature. 1965;208:795–796.

Kasakura S, Lowenstein L. DNA and RNA synthesis and the formation of blastogenic factor in mixed leukocyte cultures.Nature. 1967;215:80–81.

Dumonde DC, Wolstencroft RA, Panayi GS, Matthew M, Morley J, Howson WT. Lymphokines: non-antibody mediators of cellular immunity generated by lymphocyte activation.Nature. 1969;224:38–42.

Kasakura S. Heterogeneity of blastogenic factors produced in vitro by antigenically stimulated and unstimulated leukocytes.J Immunol. 1970;105:1162–1167.

Kasakura S. A blastogenic factor in unidirectional mixed leukocyte cultures with x-irradiated cells.Transplantation. 1971;11:117–121.

Gery I, Gershon RK, Waksman BH. Potentiation of cultured mouse thymocyte responses by factors released by peripheral leukocytes.J Immunol. 1971;107:1778–1780.

Gery I, Waksman BH. Potentiation of lymphocyte responses to mitogens. II. The cellular source of potentiating mediators.J Exp Med. 1972;136:143–155.

Rosenwasser LJ, Dinarello CA, Rosenthal AS. Adherent cell function in murine T lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen.J Exp Med. 1979;150:709–714.

Cohen S, Bigazzi PE, Yoshida T. Similarities of T cell function in cell-mediated immunity and antibody production.Cell Immunol. 1974;12:150–159.

Waksman BH. Modulation of immunity by soluble mediators.Pharmacol Ther A. 1978;2:623–672.

Oppenheim JJ, Gery I. From lymphodrek to IL 1.Immunol Today. 1993;14:232–234.

Mizel SB, Farrar JJ. Revised nomenclature for antigen non-specific T cell proliferation and helper factors.Cell Immunol. 1970;48:433–436.

Morgan DA, Ruscetti FW, Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows.Science. 1976;193:1007–1008.

Zubler RM, Lowenthal JW, Erard F, Hashimoto N, Devos R, Mac Donald HR. Activated B cells express receptors for and proliferate in response to pure IL-2.J Exp Med. 1984;160:1170–1183.

Ortaldo JRM, Mason AT, Gerard JP, et al. Effects of natural and recombinant IL 2 on regulation of IFNγ production and natural killer cell activity.J Immunol. 1984;133:779–783.

Oppenheim JJ, Gery I. Interleukin 1 is more than an interleukin.Immunol Today. 1982;3:113–119.

Ihle JN, Pepersack L, Rebar L. Regulation of T cell differentiation: in vitro induction of 20a hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine.J Immunol. 1981;126:2184–2189.

Taniguchi T, Ohno S, Fujii-Kuriyama Y, Muratmatsu M. The nucleotide sequence of human fibroblast interferon cDNA.Gene. 1980;10:11–15.

Nagata S, Taira H, Hall A, et al. Synthesis in E. coli of a polypeptide with human leukocyte interferon activity.Nature. 1980;284:316–320.

Gray PW, Leung DW, Pennica D, et al. Expression of human immune interferon cDNA inE. coli and monkey cells.Nature. 1982;285:503–508.

Taniguchi T, Matsui H,Fujita T, et al. Structure and expression of a cloned cDNA for human interleukin-2.Nature. 1983;302:305–310.

Leonard WJ, Depper JM, Crabtree GR, et al. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor.Nature. 1984;311:626–631.

Pennica D, Nedwin GE, Hayflick JS, et al. Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin.Nature. 1984;312:724–729.

Gray PW, Aggarwal BB, Benton CV, et al. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumor necrosis activity.Nature. 1984;312:721–724.

Durum SK, Muegge K, eds.Contemporary Immunology: Cytokine Knockouts. Totowa, NJ: Pub Humana Press; 1998.

Nagata S. Apoptosis by death factor.Cell. 1997;88:355–365.

Derynck R, Jarrett JA, Chen EY, et al. Human transforming growth factor-B complementary DNA sequence and expression in normal and transformed cells.Nature. 1985;316:701–705.

Moore K, O’Garra A, de Waal Malefyt R, Viera P, Mosmann TR. Interleukin 10.Annu Rev Immunol. 1993;11:165–190.

Ward PA, Remold HG, David JR. Leukotactic factor produced by sensitized lymphocytes.Science. 1969;163:1079–1081.

Luger TA, Charon JA, Colot M, Miksche M, Oppenheim JJ. Chemotactic properties of partially purified human epidermal cell-derived thymocyte activating factor CETAF for polymorphonuclear and mononuclear cells.J Immunol. 1983;13:816–820.

Sauder DN, Mounessa NL, Katz SI, Dinarello CA, Gallin JI. Chemotactic cytokines: the role of leukocyte pyrogen and ETAF in neutrophil chemotaxis.J Immunol. 1984;132:828–832.

Yoshimura T, Matsushima K,Tanaka S, et al. Purification of human monocyte-derived neutrophil chemotactic factor that shares sequence homology with other host defense cytokines.Proc Natl Acad Sci U S A. 1987;84:9233–9237.

Matsushima K, Morishita K, Yoshimura T, et al. Molecular cloning of cDNA for a human monocyte derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.J Exp Med. 1988;167:1883–1893.

Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. Identity of chemotactic cytokine for T-lymphocytes with neutrophil activating protein (NAP-1): a candidate interleukin 8.Science. 1989;243:1464–1466.

Hirano T, Yasukawa K, Harada H, et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.Nature. 1986;324:73–76.

Zilberstein A, Ruggieri R, Korn JH, Revel M. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines.EMBO J. 1986;5:2529–2537.

Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns.FASEB J. 1991;5:171–177.

Yssel H, DeWaal MR, Roncarolo M-G, et al. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells.J Immunol. 1992;149:2378–2384.

Hsieh GS, Macatonia SE, Tripp CS, Wolf SF, O’Garra A, Murphy KM. Listeria induced TH1 development in afjTCR transgenic CD4+ T cells occurs through macrophage production of IL-12.Science. 1992;260:547–549.

Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell RA. Interleukin (IL)-6 directs the differentiation of IL-4 producing CD4+ T cells.J Exp Med. 1997;185:461–469.

Oppenheim JJ, Neta R. Pathophysiological roles of cytokines in development, immunity and inflammation.FASEB J. 1994;8:158–162.

Oppenheim JJ, Saklatvala J. Cytokines and their receptors. In: Oppenheim JJ, Rossio JL, Gearing AJH, eds.Clinical Applications of Cytokines. New York, NY: Oxford University Press; 1993:3–15.

Russell SM, Keegan AD, Harada N, et al. IL-2 receptor — chains. A functional component of the IL-4 receptor.Science. 1993;262:1880–1883.

Miyajima A, Kitamura T, Harada N, Yokota T, Arai K-I. Cytokine receptors and signal transduction.Am Rev Immunol. 1992;10:298–332.

Taga T, Kishimoto T. GP130 and the interleukin-6 family of cytokines.Annu Rev Immunol. 1997;15:797–819.